
Academia, CROs, and industry must work together to create novel therapies with acceptable safety profiles.

Explore a key way to view the CRO dynamic, for virtual companies: The CRO as a part of a virtual companyâs drug discovery team.

An honest discussion from the client perspective on gaining access to complex assays and services.

Experts explore how to adapt what already exists, and how to optimize, customize, and innovate to help clients meet their goals.

A lively discussion on growing scientific knowledge, technological development, and more sophisticated in vitro non-animal alternatives.

Experts say a variety of approaches that include the BioMAPÂŽ Platform, as well as continued innovation, are needed.